UnitedHealth Group revealed additional details about the compensation package for CEO Stephen Hemsley in a filing with the Securities and Exchange Commission. | UnitedHealth Group revealed additional details about the compensation package for CEO Stephen Hemsley in a filing with the Securities and Exchange Commission.

Stephen Hemsley ran UnitedHealth Group for more than a decade. It's a different company after four years with Andrew Witty in charge.

UnitedHealth's stock has plunged nearly 40% year-to-date as the company has battled a series of crises. Can the healthcare giant turn it around? Seeking Alpha analysts weigh in.

Stephen Hemsley hasn’ t been CEO at UnitedHealth Group in nearly a decade yet he’ s never really left. Since that day, the company’ s stock has fallen from $610 a share to $308 on Tuesday, an unprecedented decline for the company that culminated in this week’ s CEO transition.

UnitedHealth has faced several headwinds in the recent past, ranging from a cyberattack, which had greater than initially realized impacts, to the tragic killing of its CEO, which caused the company to suffer harsh public backlash over the company's and industry practices.

Even UnitedHealth will struggle to overcome parasitic medical costs that Warren Buffett once called a tapeworm eating away at U.S. economic competitiveness. The $300 billion healthcare conglomerate reinstalled Chairman Stephen Hemsley as CEO and yanked its financial guidance.

UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal issues, creating a potential buying opportunity. The stock is deeply oversold with an RSI of 15, trading below both the 200-day and 50-day moving averages, indicating capitulation.

UnitedHealth Group, the largest health insurer in the country, is turning back the clock in a moment of crisis. On Tuesday, the company announced that chairman Stephen Hemsley is returning as CEO, stepping back into the role he left in 2017.